To get the full picture of the global market situation, companies use various sources of data. But to effectively control and steer business activity at all levels on global scale they need a centralized and trustworthy data source.
Scientists are working on new ways to develop vaccines, with the so-called reverse vaccinology (or Vaccinology 3.0) being one of the main trends. This method of vaccine development is fast, but it requires screening the entire pathogen genome. It's a world of huge volumes of data.
New digital solutions are currently pouring into what used to be a rather conservative area: regulated industries, as they are in constant need of real-time reviewing of their progress to meet market regulations and synchronize information of their multi-level structure.